Episodes

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: 23andMe’s intended entry into telehealth with the acquisition of Lemonaid Health (00:35), the Center for Medicare & Medicaid Innovation strategic plan refresh (04:15), a new partnership between Walmart and Transcarent (08:13), and the launch of virtual-first health plans (10:55) Podcast Tags: primary care, genetic testing, telehealth, CMMI, Medicare, self-insured employers, health plans, healthcare, healthca...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: 23andMe’s intended entry into telehealth with the acquisition of Lemonaid Health (00:35), the Center for Medicare & Medicaid Innovation strategic plan refresh (04:15), a new partnership between Walmart and Transcarent (08:13), and the launch of virtual-first health plans (10:55) Podcast Tags: primary care, genetic testing, telehealth, CMMI, Medicare, self-insured employers, health plans, healthcare, healthca...

With the explosion of digital channels and accompanying shifts in customer preferences, life sciences are reshaping their customer engagement models across commercial, medical, and market access organizations. In this episode, Jen and Mindy are joined by special guest Hunter Goga to how the customer engagement model has evolved and what leaders should be considering from a compliance perspective as they look to innovate in this space. Traditionally siloed interactions are evolving (00:47) in bot...

With the explosion of digital channels and accompanying shifts in customer preferences, life sciences are reshaping their customer engagement models across commercial, medical, and market access organizations. In this episode, Jen and Mindy are joined by special guest Hunter Goga to how the customer engagement model has evolved and what leaders should be considering from a compliance perspective as they look to innovate in this space. Traditionally siloed interactions are evolving (00:47) in bot...

With the explosion of digital channels and accompanying shifts in customer preferences, life sciences are reshaping their customer engagement models across commercial, medical, and market access organizations. In this episode, Jen and Mindy are joined by special guest Hunter Goga to how the customer engagement model has evolved and what leaders should be considering from a compliance perspective as they look to innovate in this space. Traditionally siloed interactions are evolving (00:47) in bot...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in COVID-19 vaccines and treatments (00:34), updates on Pfizer’s copay assistance legal battle (03:55) and surprise billing arbitration (06:30), and the start of Medicare Advantage & Part D open enrollment (10:42). Podcast Tags: COVID-19, vaccines, Medicare, Medicare Advantage, surprise billing, copay assistance, healthcare, healthcare news Source Links: · https://www.nytimes.com/2021/09/22/us/p...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in COVID-19 vaccines and treatments (00:34), updates on Pfizer’s copay assistance legal battle (03:55) and surprise billing arbitration (06:30), and the start of Medicare Advantage & Part D open enrollment (10:42). Podcast Tags: COVID-19, vaccines, Medicare, Medicare Advantage, surprise billing, copay assistance, healthcare, healthcare news Source Links: · https://www.nytimes.com/2021/09/22/us/p...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in COVID-19 vaccines and treatments (00:34), updates on Pfizer’s copay assistance legal battle (03:55) and surprise billing arbitration (06:30), and the start of Medicare Advantage & Part D open enrollment (10:42). Podcast Tags: COVID-19, vaccines, Medicare, Medicare Advantage, surprise billing, copay assistance, healthcare, healthcare news Source Links: · https://www.nytimes.com/2021/09/22/us/p...

The recent proliferation and adoption of digital health technologies is often heralded as a key mechanism in closing the gap when it comes to health disparities. In this episode, Jen and Mindy are joined by special guest DJ O’Connor to discuss equality barriers in digital health and how healthcare leaders can develop more equitable solutions. The pandemic has accelerated the availability and adoption of digital healthcare, socioeconomic disparities prevent vulnerable populations from accessing f...

The recent proliferation and adoption of digital health technologies is often heralded as a key mechanism in closing the gap when it comes to health disparities. In this episode, Jen and Mindy are joined by special guest DJ O’Connor to discuss equality barriers in digital health and how healthcare leaders can develop more equitable solutions. The pandemic has accelerated the availability and adoption of digital healthcare, socioeconomic disparities prevent vulnerable populations from accessing f...

The recent proliferation and adoption of digital health technologies is often heralded as a key mechanism in closing the gap when it comes to health disparities. In this episode, Jen and Mindy are joined by special guest DJ O’Connor to discuss equality barriers in digital health and how healthcare leaders can develop more equitable solutions. The pandemic has accelerated the availability and adoption of digital healthcare, socioeconomic disparities prevent vulnerable populations from accessing f...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11). Podcast Tags: reproductive health, gene therapy, Medicare, FDA, healthcare, healthcare news Source Links: · https://www.documentcloud.org/docum...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11). Podcast Tags: reproductive health, gene therapy, Medicare, FDA, healthcare, healthcare news Source Links: · https://www.documentcloud.org/docum...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11). Podcast Tags: reproductive health, gene therapy, Medicare, FDA, healthcare, healthcare news Source Links: · https://www.documentcloud.org/docum...

Patient centricity is no longer a buzzword, it\’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improv...

Patient centricity is no longer a buzzword, it\’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improv...

Patient centricity is no longer a buzzword, it\’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improv...

Patient centricity is no longer a buzzword, it's redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improvi...

Patient centricity is no longer a buzzword, it's redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improvi...

Patient centricity is no longer a buzzword, it's redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and partnership are defining featured of a truly patient centric approach (00:41). There are opportunities for improvi...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the impact of the Delta variant on the healthcare system (00:31), a crackdown on “pay for delay” in the generic space (05:53), and the fight to legalize Medicare copay assistance (09:25). Podcast Tags: COVID-19, vaccination, drug prices, generics, biosimilars, Medicare, copays, healthcare, healthcare news Source Links: · https://khn.org/news/article/unraveling-the-mysterious-mutations-that-make-delta-the-mo...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the impact of the Delta variant on the healthcare system (00:31), a crackdown on “pay for delay” in the generic space (05:53), and the fight to legalize Medicare copay assistance (09:25). Podcast Tags: COVID-19, vaccination, drug prices, generics, biosimilars, Medicare, copays, healthcare, healthcare news Source Links: · https://khn.org/news/article/unraveling-the-mysterious-mutations-that-make-delta-the-mo...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the impact of the Delta variant on the healthcare system (00:31), a crackdown on “pay for delay” in the generic space (05:53), and the fight to legalize Medicare copay assistance (09:25). Podcast Tags: COVID-19, vaccination, drug prices, generics, biosimilars, Medicare, copays, healthcare, healthcare news Source Links: · https://khn.org/news/article/unraveling-the-mysterious-mutations-that-make-delta-the-mo...

Climbing COVID-19 vaccination rates have enabled many countries to relax social distancing requirements and business leaders to implement their return to workplace plans. In this episode, Ryan and Jen are joined by Vynamic’s Lauren Scandone and Stefanie Christmas to discuss the importance of culture in developing and executing those plans. The past eighteen months have irrevocably changed how many employers and employees think about work – bringing technology, employee choice, and empathy to the...